Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 388

1.

The clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy.

Hayde N, Bao Y, Pullman J, Ye B, Calder RB, Chung M, Schwartz D, Lubetzky M, Ajaimy M, de Boccardo G, Akalin E.

Clin J Am Soc Nephrol. 2013 Dec;8(12):2141-8. doi: 10.2215/CJN.04240413. Epub 2013 Sep 12.

2.

The clinical and molecular significance of C4d staining patterns in renal allografts.

Hayde N, Bao Y, Pullman J, Ye B, Calder BR, Chung M, Schwartz D, Alansari A, de Boccardo G, Ling M, Akalin E.

Transplantation. 2013 Feb 27;95(4):580-8. doi: 10.1097/TP.0b013e318277b2e2.

PMID:
23274969
3.

Clinical and pathological analyses of transplant glomerulopathy cases.

Shimizu T, Ishida H, Toki D, Nozaki T, Omoto K, Tanabe K, Honda K, Koike J.

Nephrology (Carlton). 2014 Jun;19 Suppl 3:21-6. doi: 10.1111/nep.12243.

PMID:
24842817
4.

Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.

Sis B, Halloran PF.

Curr Opin Organ Transplant. 2010 Feb;15(1):42-8. doi: 10.1097/MOT.0b013e3283352a50. Review.

PMID:
20009933
5.

Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.

Kikić Ž, Kainz A, Kozakowski N, Oberbauer R, Regele H, Bond G, Böhmig GA.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1435-43. doi: 10.2215/CJN.09901014. Epub 2015 Jun 12.

6.

Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining.

Akalin E, Dinavahi R, Dikman S, de Boccardo G, Friedlander R, Schroppel B, Sehgal V, Bromberg JS, Heeger P, Murphy B.

Clin J Am Soc Nephrol. 2007 Nov;2(6):1261-7. Epub 2007 Oct 17.

7.

The impact of C4d staining as a humoral injury marker.

Kara M, Demir F, Ata P, Ozel L, Gumrukcu G, Unal E, Canbakan M, Gucun M, Esadoglu V, Ozdemir E, Cemel H, Titiz MI.

Transplant Proc. 2012 Jul-Aug;44(6):1694-6. doi: 10.1016/j.transproceed.2012.05.029.

PMID:
22841245
8.

Donor-specific anti-HLA antibodies in pediatric renal transplant recipients with creeping creatinine: Prevalence, histological correlations, and impact on patient and graft survival.

Monteverde ML, Chaparro A, Goldberg J, Marcos CY, Padros K, Balbarrey Z, Briones L, Rush D.

Pediatr Transplant. 2015 Nov;19(7):684-90. doi: 10.1111/petr.12556. Epub 2015 Jul 24.

PMID:
26212912
9.

Significance and implications of capillaritis during acute rejection of kidney allografts.

Cosio FG, Lager DJ, Lorenz EC, Amer H, Gloor JM, Stegall MD.

Transplantation. 2010 May 15;89(9):1088-94. doi: 10.1097/TP.0b013e3181d368f1.

PMID:
20216485
10.

Clinical, Histological, and Molecular Markers Associated With Allograft Loss in Transplant Glomerulopathy Patients.

Kamal L, Broin PÓ, Bao Y, Ajaimy M, Lubetzky M, Gupta A, de Boccardo G, Pullman J, Golden A, Akalin E.

Transplantation. 2015 Sep;99(9):1912-8. doi: 10.1097/TP.0000000000000598.

PMID:
25675205
11.

Banff 2013 update: Pearls and pitfalls in transplant renal pathology.

Hara S.

Nephrology (Carlton). 2015 Jul;20 Suppl 2:2-8. doi: 10.1111/nep.12474. Review.

PMID:
26031578
12.

Pathology of C4d-negative antibody-mediated rejection in renal allografts.

Haas M.

Curr Opin Organ Transplant. 2013 Jun;18(3):319-26. doi: 10.1097/MOT.0b013e32835d4daf. Review.

PMID:
23283250
13.
14.

Probable C4d-negative accelerated acute antibody-mediated rejection due to non-HLA antibodies.

Niikura T, Yamamoto I, Nakada Y, Kamejima S, Katsumata H, Yamakawa T, Furuya M, Mafune A, Kobayashi A, Tanno Y, Miki J, Yamada H, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T.

Nephrology (Carlton). 2015 Jul;20 Suppl 2:75-8. doi: 10.1111/nep.12467. Review.

PMID:
26031592
15.

Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.

Lawrence C, Willicombe M, Brookes PA, Santos-Nunez E, Bajaj R, Cook T, Roufosse C, Taube D, Warrens AN.

Transplantation. 2013 Jan 27;95(2):341-6. doi: 10.1097/TP.0b013e3182743cfa.

PMID:
23197178
16.

Donor-specific antibodies, C4d and their relationship with the prognosis of transplant glomerulopathy.

Lesage J, Noël R, Lapointe I, Côté I, Wagner E, Désy O, Caumartin Y, Agharazii M, Batal I, Houde I, De Serres SA.

Transplantation. 2015 Jan;99(1):69-76. doi: 10.1097/TP.0000000000000310.

PMID:
25073036
17.

Microvascular inflammation in early protocol biopsies of renal allografts in cases of chronic active antibody-mediated rejection.

Tsuji T, Yanai M, Itami H, Ishii Y, Akimoto M, Fukuzawa N, Harada H, Fukasawa Y.

Nephrology (Carlton). 2015 Jul;20 Suppl 2:26-30. doi: 10.1111/nep.12450.

PMID:
26031582
18.

Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification.

Mauiyyedi S, Crespo M, Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Tolkoff-Rubin NE, Williams WW, Delmonico FL, Cosimi AB, Colvin RB.

J Am Soc Nephrol. 2002 Mar;13(3):779-87.

20.

Expression patterns of B cells in acute kidney transplant rejection.

Carpio VN, Noronha Ide L, Martins HL, Jobim LF, Gil BC, Külzer AS, Loreto Mda S, Gonçalves LF, Manfro RC, Veronese FV.

Exp Clin Transplant. 2014 Oct;12(5):405-14.

Supplemental Content

Support Center